Next 10 |
2024-03-29 07:00:00 ET Summary The market is near record highs and NVDA is up 11 straight weeks. Yet, blue-chip coiled spring bargains are still bountiful. VFLO is the best deep value strategy ETF I've found. A great combo of deep value, quality, and growth. It's beating the S&...
2024-03-28 10:00:53 ET More on CVS, Elevance Health, etc. Elevance: A Healthy Dose Of Dividend Growth Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront CVS Health: Here Comes The Floor - Inherent Undervaluation Triggers Great Upside Potential ...
2024-03-28 06:33:44 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run John...
2024-03-26 10:54:57 ET More on Humana Humana: This Year's Drop Might Have Created A Buying Opportunity Humana: Solid Growth Prospects Despite Cost Challenges Humana: A Golden Buying Opportunity As Fears Potentially Peaked Humana prices $2.25B debt offering ...
2024-03-24 08:37:16 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-03-22 09:25:36 ET More on markets Nasdaq, S&P, and Dow futures notice limited movement while yields tick down Dividend Roundup: JPMorgan Chase, Starbucks, CVS Health, Mondelez, and more S&P 500 and 20% of its holdings flash overbought signals, according ...
2024-03-22 07:29:03 ET This week's dividend activity included increased payouts from JPMorgan Chase ( NYSE: JPM ) and FirstEnergy ( FE ) as well as declarations from companies like Starbucks ( NASDAQ: SBUX ) and CVS Health ( NYSE: CVS ) . ... Read the f...
2024-03-21 13:35:23 ET More on Eli Lilly, Novo Nordisk, etc. Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Confer...
Humana Inc . (NYSE: HUM) and DUOS , a technology-enabled service provider announces a new collaborative program to enhance the healthcare experience and improve health outcomes for Louisiana Veteran members with chronic conditions. This press release features multimedia. View the full r...
2024-03-18 23:26:49 ET Summary Humana's earnings guidance for 2024 and 2025 fell short of analysts' expectations, driven by challenges in its Medicare Advantage business segment. Analysts have drastically cut their income projections for HUM, but still expect the company to grow i...
News, Short Squeeze, Breakout and More Instantly...
The first quarter of 2024 has turned out to be a blockbuster for most asset classes, and the strong performances have left investors worried abou...
The first quarter of 2024 has turned out to be a blockbuster for most asset classes, and the strong performances have left investors worried abou...
Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV), and Kaiser Permanente wil...